List view / Grid view
25 May 2016 | By Victoria White, Digital Content Producer
MJFF is to fund two projects leveraging the promise of engineered stem cells to speed new therapies and deeper understanding of Parkinson's disease...
11 May 2016 | By Victoria White, Digital Content Producer
Scientists have proven that a model of the human gut - HuMiX - is representative of the actual conditions and processes that occur within our intestines...
3 May 2016 | By Victoria White, Digital Content Producer
Oral administration of a Jakinib lessened the destructive inflammation and nerve cell degradation in the area of the brain affected by Parkinson's...
28 April 2016 | By Victoria White, Digital Content Producer
Su-Chun Zhang created two related cell types. When the cells detect the designer drug, one type ramps up production of dopamine; the other chokes it off...
21 April 2016 | By Victoria White, Digital Content Producer
Researchers have mapped out the pathways of a set of neurons responsible for the kinds of motor impairments found in patients with Parkinson's disease...
15 March 2016 | By Victoria White
Their work could help unravel how and why people develop Parkinson’s, and aid in the search for potential treatments...
2 March 2016 | By Victoria White
Researchers looked at the metabolism of neurons lacking DJ1 and discovered that two key metabolic pathways are affected...
1 March 2016 | By Victoria White
The AChE peptide has been shown to drive production of both amyloid and hyperphosphorylated tau in Alzheimer's disease...
21 January 2016 | By Hans Fliri PhD, Chairman, Cypralis
Here, Dr Hans Fliri, Chairman and CEO of Selcia and Chairman of Cypralis, presents a strong case for targeting mitochondrial cyclophilin D to prevent progression of chronic neurodegenerative diseases...
13 January 2016 | By Victoria White
The discovery, made by BUSM scientists, may lead to a better understanding of the disease, early diagnosis and therapeutic development...
8 January 2016 | By Victoria White
The partnership will focus on the delivery of recombinant Glial Cell Line-Derived Neurotrophic Factor to affected brain regions by way of implanted, encapsulated cell therapy devices...
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
7 December 2015 | By Victoria White
Parkinson’s disease researchers at the University at Buffalo have developed a way to ramp up the conversion of skin cells into dopamine neurons...
19 November 2015 | By Victoria White
Scientists have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue...
10 November 2015 | By Victoria White
In preclinical studies, researchers showed that PXT-864, a combination of baclofen and acamprosate, improved multiple endpoints associated with the development and progression of Parkinson's disease...
